Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPG Block for Post-Thoracotomy Shoulder Pain
NCT02733393Phase 1Completed
- Sponsor
- NYU Langone Health
- Start
- Sep 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lidocaine, sponsored by NYU Langone Health. Primary endpoint: Reduction of Shoulder Pain at 90 months. Started Sep 2015; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NCT02733393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733393.